Tanaka Satoshi, Shimooka Shohachi, Shimomura Hiromi
Department of Pediatric Dentistry, School of Dentistry at Niigata, The Nippon Dental University, 1-8 Hamaura-cho, Niigata 951-8580, Japan.
Arch Oral Biol. 2002 Aug;47(8):567-76. doi: 10.1016/s0003-9969(02)00049-3.
Developmental changes (from 2 to 26 weeks) in phosphodiesterase (PDE) activity in the rat submandibular gland were investigated. Major activities for both cAMP- and cGMP-PDE were present in the 100000 x g supernatant fractions (70-90% of total activities), but not in the pellet fractions, during development. The effects of stimulators (Ca(2+)/calmodulin and cGMP) and inhibitors (cGMP, cilostamide, rolipram and zaprinast) were investigated in the supernatant fractions. During development, PDE4 (cAMP-specific PDE) was a major PDE, indicating that the majority of cAMP is hydrolysed by PDE4. In the young rat, PDE1 hydrolysed cGMP three-fold more than the control, and PDE2 (cGMP-stimulated PDE) was present, indicating that the concentration of intracellular cGMP may be enhanced, and cGMP may function in the growth pathway in the submandibular gland. Chromatograms eluted on a Mono Q HR5/5 ion-exchange column supported the results of the inhibition studies: PDE1, PDE2, PDE3, PDE4 and PDE5 were present in the young submandibular gland, and PDE1, PDE3, PDE4 and PDE5 in the adult gland. Expression of PDE5 was detected by inhibition studies, reverse transcriptase-polymerase chain reaction and Western blotting in the submandibular gland.
研究了大鼠下颌下腺磷酸二酯酶(PDE)活性在发育过程中的变化(从2周到26周)。在发育过程中,cAMP - PDE和cGMP - PDE的主要活性存在于100000×g上清液部分(占总活性的70 - 90%),而沉淀部分没有。在上清液部分研究了刺激剂(Ca(2 +)/钙调蛋白和cGMP)和抑制剂(cGMP、西洛他唑、咯利普兰和扎普司特)的作用。在发育过程中,PDE4(cAMP特异性PDE)是主要的PDE,表明大部分cAMP由PDE4水解。在幼鼠中,PDE1水解cGMP的能力比对照组高三倍,并且存在PDE2(cGMP刺激的PDE),这表明细胞内cGMP的浓度可能会升高,并且cGMP可能在颌下腺的生长途径中发挥作用。在Mono Q HR5/5离子交换柱上洗脱的色谱图支持了抑制研究的结果:幼龄下颌下腺中存在PDE1、PDE2、PDE3、PDE4和PDE5,成年腺体中存在PDE1、PDE3、PDE4和PDE5。通过抑制研究、逆转录聚合酶链反应和蛋白质印迹法在颌下腺中检测到了PDE5的表达。